cromolyn sodium has been researched along with 3-hydroxyflavone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertrand, C; Landry, Y; Tschirhart, E | 1 |
| Cho, H; Elmaleh, DR; Hori, Y; Hudry, E; Hyman, BT; Irimia, D; Shoup, TM; Takahashi, K; Takeda, S; Wegmann, S | 1 |
2 other study(ies) available for cromolyn sodium and 3-hydroxyflavone
| Article | Year |
|---|---|
Nedocromil sodium inhibits IgE- and IgG-related antigen-induced contraction in guinea-pig trachea.
Topics: Airway Resistance; Anaphylaxis; Animals; Benzoquinones; Chromones; Cromolyn Sodium; Flavonols; Guinea Pigs; Immunoglobulin E; Immunoglobulin G; In Vitro Techniques; Male; Nedocromil; Ovalbumin; Pyrilamine; Quercetin; Quinolones; Quinones; Trachea | 1989 |
A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cells, Cultured; Cromolyn Sodium; Disease Models, Animal; Drug Approval; Flavonoids; Flavonols; Humans; Mice; Mice, Transgenic; Microglia; Microscopy, Electron, Transmission; Peptide Fragments; United States; United States Food and Drug Administration | 2015 |